RINVOQ upadacitinib 45 mg modified release tablet blister pack

AbbVie Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8f12edb091102d10
Product Name: RINVOQ upadacitinib 45 mg modified release tablet blister pack
Artg Id: 375857
Artg Name: RINVOQ upadacitinib 45 mg modified release tablet blister pack
Sponsor: AbbVie Pty Ltd
Company Detail Path: /organization/abbvie-pty-ltd
Artg Date: 2022-09-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/7bb56c02342a7bec3d9dc58f23d11e97.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f1ef25397dc91604d09c47624262cacb.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

8f12edb091102d10

Type

Standard